Seeking Alpha

Insulet slips 2.5% pre-market on JMP downgrade

  • Shares of Insulet (PODD) slip 2.5% pre-market after JMP Securities downgrades the insulin device manufacturer to Perform from Outperform, citing increased reports in the FDA's MAUDE database, negative customer feedback online, and higher-than-expected failure rates.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: